Review article · 2026 · Open access
Alzheimer’s Disease: A Systematic Review of Novel Therapies and Vaccines
Berkeley Pharma Tech Journal of Medicine, 6(1), 80–100 · Published 6 January 2026 · DOI 10.52243/bptjm.v6i1.76
In brief
“Alzheimer’s Disease: A Systematic Review of Novel Therapies and Vaccines” is a 2026 review article by Maham Kazmi and 3 co-authors, published in Berkeley Pharma Tech Journal of Medicine. OpenAlex counts 1 citations as of 15 November 2026, which puts it in the top 9% of works published in 2026 by citations. It is open access under a CC BY licence: the full text is free to read at Berkeley Pharma Tech Journal of Medicine.
- Citations
- 1
- Most cited in
- 2026 (1)
- Field-weighted impact
- 0.58
- References
- 21
- Authors
- 4
Abstract
Alzheimer’s disease (AD) is a neurodegenerative disorder and the fifth leading cause of death in the United States as of 2021. Current FDA-approved therapies, including cholinesterase inhibitors (donepezil, rivastigmine, galantamine) and memantine, provide symptomatic relief but do not modify disease progression. The anti-amyloid monoclonal antibodies, lecanemab and donanemab, modestly slow cognitive and functional decline in early-stage AD. This review provides a comprehensive overview of the mechanisms underlying AD and research efforts aimed at understanding and treating the disease. Additionally, this paper explores ongoing clinical trials investigating novel treatments such as immunotherapies and small-molecular inhibitors targeting AD biomarkers. Regenerative medicine approaches, including gene and stem cell therapies, show promise in these trials. By understanding current research and future potential for these trials, this review aims to explore strategies for managing and potentially curing AD.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Kazmi, M., Grewal, G., Mathew, A., & Nee, J. (2026). Alzheimer’s Disease: A Systematic Review of Novel Therapies and Vaccines. Berkeley Pharma Tech Journal of Medicine, 6(1), 80–100. https://doi.org/10.52243/bptjm.v6i1.76
MLA 9
Kazmi, Maham, et al. “Alzheimer’s Disease: A Systematic Review of Novel Therapies and Vaccines.” Berkeley Pharma Tech Journal of Medicine, vol. 6, no. 1, 2026, pp. 80–100. https://doi.org/10.52243/bptjm.v6i1.76.
Chicago
Kazmi, Maham, Guneet Grewal, Alicia Mathew, and Jocelyn Nee. 2026. “Alzheimer’s Disease: A Systematic Review of Novel Therapies and Vaccines.” Berkeley Pharma Tech Journal of Medicine 6 (1): 80–100. https://doi.org/10.52243/bptjm.v6i1.76.
Harvard
Kazmi, M. et al. (2026) ‘Alzheimer’s Disease: A Systematic Review of Novel Therapies and Vaccines’, Berkeley Pharma Tech Journal of Medicine, 6(1), pp. 80–100. doi:10.52243/bptjm.v6i1.76.
IEEE
M. Kazmi, G. Grewal, A. Mathew, and J. Nee, “Alzheimer’s Disease: A Systematic Review of Novel Therapies and Vaccines,” Berkeley Pharma Tech Journal of Medicine, vol. 6, no. 1, pp. 80–100, 2026, doi: 10.52243/bptjm.v6i1.76.
BibTeX
@article{kazmi2026alzheimer,
title = {{Alzheimer’s Disease: A Systematic Review of Novel Therapies and Vaccines}},
author = {Kazmi, Maham and Grewal, Guneet and Mathew, Alicia and Nee, Jocelyn},
journal = {Berkeley Pharma Tech Journal of Medicine},
year = {2026},
volume = {6},
number = {1},
pages = {80--100},
doi = {10.52243/bptjm.v6i1.76},
url = {https://doi.org/10.52243/bptjm.v6i1.76}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Alzheimer's disease
- new drugs
- anti-amyloid monoclonal antibodies
- lecanemab
- donanemab
- cholinesterase inhibitors
- memantine
- immunotherapy
Work with this paper
Most-cited papers in Neuroscience
- The Rat Brain in Stereotaxic CoordinatesGeorge Paxinos, CHARLES R. R. WATSON · Elsevier eBooks · 1982 · 52,413 citations
- The assessment and analysis of handedness: The Edinburgh inventoryRichard Charles Oldfield · Neuropsychologia · 1971 · 36,725 citations
- EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysisArnaud Delorme A, Scott Makeig · Journal of Neuroscience Methods · 2004 · 25,302 citations
- The Ecological Approach to Visual PerceptionMarc H. Bornstein, James J. Gibson · Journal of Aesthetics and Art Criticism · 1980 · 22,977 citations
- The Psychophysics ToolboxDavid H. Brainard · Spatial Vision · 1997 · 20,208 citations
Questions about this paper
How do I cite this paper in APA style?
Kazmi, M., Grewal, G., Mathew, A., & Nee, J. (2026). Alzheimer’s Disease: A Systematic Review of Novel Therapies and Vaccines. Berkeley Pharma Tech Journal of Medicine, 6(1), 80–100. https://doi.org/10.52243/bptjm.v6i1.76
How many times has this paper been cited?
1 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at Berkeley Pharma Tech Journal of Medicine.
Who wrote this paper?
Maham Kazmi, Guneet Grewal, Alicia Mathew, Jocelyn Nee.
What is the DOI of this paper?
10.52243/bptjm.v6i1.76. The permanent link is https://doi.org/10.52243/bptjm.v6i1.76.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.